🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST

Maxigen Biotech Revenue

Maxigen Biotech had revenue of 220.38M TWD in the quarter ending September 30, 2026, with 9.72% growth. This brings the company's total for the last twelve months to 856.96M, up 8.14% year-over-year. In the year 2025, Maxigen Biotech had annual revenue of 811.56M with 19.23% growth. That makes Maxigen Biotech the 32,314th largest company in the world by revenue and 1,670th in Taiwan.

Revenue (ttm)
856.96M
Revenue Growth
+8.14%
P/S Ratio
3.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.85B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Europe and America 328.86M 40.5%
  • Taiwan 322.95M 39.8%
  • Asia 154.27M 19.0%
  • Other Regions 5.48M 0.7%

By Geography

Chart
  • Europe and America 328.86M 40.5%
  • Taiwan 322.95M 39.8%
  • Asia 154.27M 19.0%
  • Others 5.48M 0.7%
Fiscal year ended Dec 31, 2025 See the full Maxigen Biotech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025811.56M130.91M19.23%
Dec 31, 2024680.65M58.54M9.41%
Dec 31, 2023622.12M17.68M2.93%
Dec 31, 2022604.43M92.46M18.06%
Dec 31, 2021511.98M54.29M11.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.